Translating lab discoveries into clinically validated, multi-tiered polysaccharide formulations through end-to-end CDMO pipelines.
The international landscape for polysaccharides has transitioned from crude precipitations to molecularly defined, glyco-structure engineered biopolymers.
Global consumption of β-glucans, arabinogalactans, and fucoidans demands precise molecular weight (Mw) consistency. Crude extracts no longer satisfy tier-1 global brands requiring documented macrophage activation and Toll-like receptor (TLR-4) binding assays.
Modified polysaccharides serve as biocompatible, biodegradable carriers for nanomedicine. Controlled chemical functionalization (carboxymethylation, sulfation) allows targeted mucosal adhesion and sustained-release micro-encapsulation matrices.
Tremella fuciformis, Dendrobium, and Poria cocos heteropolysaccharides are superseding standard sodium hyaluronate by delivering superior trans-epidermal moisture retention, ROS scavenging, and fibroblast proliferation support without tacky sensory profiles.
Formulating bio-functional polysaccharidic compounds tuned specifically to the regulatory and consumer nuances of major target jurisdictions.
Adapting immune-active fungal beta-D-glucans (Ganoderma lucidum, Hericium erinaceus) for high optical clarity, neutral palate stability, and RTD temperature resilience under cold-fill or aseptic bottling conditions.
Formulating low-viscosity, enzymatically depolymerized galactomannans and pectin oligosaccharides adhering strictly to EFSA novel food standards, engineered for microbiome modulation in metabolic cohorts.
Direct isolation of water-soluble Astragalus and Bletilla striata polysaccharides customized for ultra-low endotoxin thresholds, yielding high film-forming capabilities in post-aesthetic clinical skincare repair formulations.
Leveraging Changsha’s phytochemistry core with directly managed manufacturing plants, guaranteeing unbroken raw-material access and rapid commercial scale-up.
Integrated GAP cultivation belts across authentic geographic habitats (Daodi origins) allow precision botanical selection, locking in maximal sugar chain condensation and active yields across seasonal variants.
Our proprietary tiered ultrafiltration and continuous countercurrent extraction trains reduce energy footprints by 42% while preserving fragile carbohydrate branching structures from thermal degradation.
From 50-liter pilot research reactors to 10,000-liter commercial extraction vessels, our facility transitions novel clinical batches to multi-ton export volumes with validated batch-to-batch chromatographic symmetry.
Years Phytochemical CRO/CDMO Experience
Scientific Personnel & Extraction Engineers
Classic TCM Formulas Modernized
Single-Herb Validated Quality Standards
Integrating computational structural biology and advanced enzymatic modification to engineer next-generation macromolecular carbohydrates.
Deploying specialized endo-glycosidases to precisely trim hyper-branched heteropolysaccharides into target oligosaccharide fragments with maximized cellular bioavailability and lower immunogenic divergence.
Pioneering size exclusion chromatography coupled with multi-angle laser light scattering (SEC-MALLS) to establish absolute weight-average molar masses (Mw) and polydispersity indices (Mw/Mn) down to zero calibration drift.
Constructing covalent cross-links between selected fungal polysaccharides and functional bioactive peptide chains to create synergistic dual-mechanism therapeutic matrices for chronic mucosal defense.
Total regulatory alignment shielding partners across the United States FDA, European Union EMA/EFSA, and Asia-Pacific health authorities.
Every commercial polysaccharide product is accompanied by complete compositional breakdowns, monosaccharide ratio profiles, USP/EP residual solvent testing, heavy metal mass spec, and validated microbial bioburden certificates.
We design, conduct, and summarize GLP-compliant 90-day subchronic toxicity, Ames tests, and in vivo chromosomal aberration assays explicitly formatted for New Dietary Ingredient (NDI) or Novel Food filings.
Through strict legal and digital firewalls, client formulas, specialized enzyme cleavage kinetics, and downstream excipient matrix combinations remain completely segregated and contract-protected.
Direct technical validation conducted in partnership with top hospital clinical trial centers and pharmaceutical conglomerates.
Tongrentang Group
CR Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Dihon Pharmaceutical
Golden Throat Group
Yangtzi River Pharma
Humanwell Healthcare
Shuguang Hospital TCM
Second Xiangya HospitalCrucial answers addressing molecular standardization, scaling, analytical rigor, and OEM finished packaging.
Select from our fully audited pharmaceutical and nutritional service pipelines to start your next commercial campaign.
Connect with our senior phytochemistry scientists to review technical specifications, request analytical samples, or receive a preliminary industrial scale-up feasibility study.
